University Hospital, Brest: Polymyalgia Rheumatica trials

The registry lists 13 Polymyalgia Rheumatica studies with University Hospital, Brest as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumaticaRecruitingNCT07279688Phase 3
• Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)Not yet recruitingNCT07132164
• Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia RheumaticaNot yet recruitingNCT06558357
• Polymyalgia Rheumatica Associated to Primary Sjogren SyndromeStatus unknownNCT05312944
• Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's BiopsiesCompletedNCT04727879Not applicable
• PRediction Of DIverse Glucocorticoids toxIcity OUtcomeSActive, not recruitingNCT04664465
• Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell ArteritisCompletedNCT04204512
• BAriCitinib Healing Effect in earLy pOlymyalgia RheumaticaCompletedNCT04027101Phase 2
• Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORSCompletedNCT03632187Phase 3
• Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-DopplerCompletedNCT03360162
• Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORECompletedNCT02908217Phase 3
• Lymphocyte and Cytokine Disturbances in Polymyalgia RheumaticaCompletedNCT02888496
• Tocilizumab Effect iN pOlymyalgia RheumaticaCompletedNCT01713842Phase 2